Seizure News and Research

Latest Seizure News and Research

Researchers find clue to safer obesity drugs

Once hailed as a miracle weight-loss drug, Fen-phen was removed from the market more than a decade ago for inducing life-threatening side effects, including heart valve lesions. Scientists at UT Southwestern Medical Center are trying to understand how Fen-phen behaves in the brain in order to develop safer anti-obesity drugs with fewer side effects.

25 Nov 2008

Neurological health risk in children with blunt head injuries: fashion hair beads

An intriguing article published in the December 2008 online issue of Journal of Neurosurgery: Pediatrics may come as quite a surprise to parents, especially those with little girls.

21 Nov 2008

FDA approves tapentadol immediate-release tablets for pain in adults

Millions of Americans with moderate to severe acute pain and their health-care providers will soon have a new treatment option.

21 Nov 2008

FDA approves Banzel (rufinamide) for Lennox-Gastaut syndrome

The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.

20 Nov 2008

Discovery of new gene linked to epilepsy

A University of Iowa-led international research team has found a new gene associated with the brain disorder epilepsy.

18 Nov 2008

Discovery of gene associated with epilepsy

A University of Iowa-led international research team has found a new gene associated with the brain disorder epilepsy.

18 Nov 2008

Scientists discover new cause of fatal brain injury from acute viral meningitis

In a November 16 advance, online publication of the journal Nature, the researchers say their discovery revamps common beliefs about how such potentially lethal infections may be ravaging the brain and suggests the possibility of new treatments.

17 Nov 2008

Drops in blood oxygen levels may be key to sudden death in some epilepsy patients

A new study by researchers at UC Davis Medical Center suggests that the sudden unexplained deaths of some epilepsy patients may be a result of their brains not telling their bodies to breathe during seizures.

17 Nov 2008

Neuroprosthetic brain implants may help stroke patients overcome partial paralysis

Scientists have shown for the first time that neuroprosthetic brain implants may be able to help stroke patients with partial paralysis.

11 Nov 2008

For transient ischemic attacks both overdiagnosis and underdiagnosis can be perilous

Overdiagnosis neglects the real underlying illness. Underdiagnosis leaves a patient at risk of a full-fledged stroke. Both expose patients to erroneous therapies with potential side effects.

10 Nov 2008

New report looks at weight-loss diets, eating plans and diet pills

Over-the-counter weight-loss pills are no quick fix to melt away extra pounds.

6 Nov 2008

10 symptoms that should never be ignored

Not every ache and pain merits a quick trip to the doctor -- but some do.

6 Nov 2008

Minor shift in vaccine schedule has potential to reduce infant illness, death

A new study by researchers at Wake Forest University School of Medicine and Vanderbilt University suggests that protecting infants from a common, highly contagious and even deadly disease may be as easy as administering a routine vaccine two weeks earlier than it is typically given.

4 Nov 2008

Minor shift in vaccine schedule has potential to reduce infant illness, death

3 Nov 2008

Vaginal/Caesarean combo delivery of twins safe, UT Southwestern-led research finds

Doctors need not go straight to Caesarean section when delivering twins, but can start with vaginal delivery of the first twin in many cases, researchers have found in a study led by UT Southwestern Medical Center.

29 Oct 2008

FDA warns Bayer HealthCare on over-the-counter aspirin product

The U.S. Food and Drug Administration today sent Warning Letters to Bayer HealthCare concerning two unlawful, over-the-counter (OTC) aspirin products - Bayer Women's Low Dose Aspirin + Calcium (Bayer Women's) and Bayer Aspirin with Heart Advantage (Bayer Heart Advantage).

28 Oct 2008

A blood test for pre-eclampsia could be in the pipeline

A condition in pregnancy which costs the lives of thousands of babies each year may soon be identified by a simple blood test long before symptoms develop.

28 Oct 2008

Sedative propofol could be fatal

Patients treated for their prolonged seizures with the sedative propofol may be at high risk for complications and even death. New research presented at CHEST 2008, the 74th annual international scientific assembly of the American College of Chest Physicians (ACCP), shows that the use of propofol as an antiepileptic agent in patients with refractory status epilepticus (RSE), prolonged seizures that do not respond to initial treatment, was associated with significant mortality and morbidity.

28 Oct 2008

Keppra XR approved in the U.S. for partial onset seizures

UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Keppra XR (levetiracetam extended-release tablets) for use as an add-on to other antiepileptic treatments for people with partial onset seizures who are 16 years of age and older. Keppra XR is expected to be available in U.S. pharmacies at the end of September 2008.

15 Sep 2008

Vimpat (lacosamide) approved in Europe

UCB announced today that the European Commission (EC) has approved Vimpat (lacosamide) as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. Vimpat is the first new antiepileptic drug (AED) for partial-onset seizures in three years and offers a new treatment option for European patients living with uncontrolled partial-onset epilepsy.

3 Sep 2008